KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Molina Healthcare (MOH) Research & Development (2016 - 2018)

Historic Research & Development for Molina Healthcare (MOH) over the last 9 years, with Q1 2018 value amounting to $120.0 million.

  • Molina Healthcare's Research & Development fell 163.93% to $120.0 million in Q1 2018 from the same period last year, while for Mar 2018 it was $490.0 million, marking a year-over-year increase of 208.33%. This contributed to the annual value of $492.0 million for FY2017, which is 144.33% up from last year.
  • Latest data reveals that Molina Healthcare reported Research & Development of $120.0 million as of Q1 2018, which was down 163.93% from $123.0 million recorded in Q4 2017.
  • Molina Healthcare's Research & Development's 5-year high stood at $127.0 million during Q1 2016, with a 5-year trough of $33.0 million in Q2 2015.
  • In the last 5 years, Molina Healthcare's Research & Development had a median value of $116.0 million in 2016 and averaged $85.1 million.
  • As far as peak fluctuations go, Molina Healthcare's Research & Development tumbled by 1514.21% in 2015, and later skyrocketed by 25277.78% in 2016.
  • Quarter analysis of 5 years shows Molina Healthcare's Research & Development stood at $39.2 million in 2014, then skyrocketed by 129.77% to $90.0 million in 2015, then soared by 36.67% to $123.0 million in 2016, then changed by 0.0% to $123.0 million in 2017, then fell by 2.44% to $120.0 million in 2018.
  • Its Research & Development was $120.0 million in Q1 2018, compared to $123.0 million in Q4 2017 and $123.0 million in Q3 2017.